| Variables | Biological | Baseline | 6 months | 12 months |
|---|---|---|---|---|
| VAS | Infliximab | 66.95±24.15 | 40.81±20.87* | 29.00±16.82*** |
| Rituximab | 60.79±23.49 | 35.32±20.85** | 34.82±26.78* | |
| VGP | Infliximab | 63.52±24.78 | 39.43±21.23† | 36.74±19.91*** |
| Rituximab | 60.79±19.45 | 39.05±22.99‡ | 36.65±25.76** | |
| HAQ | Infliximab | 1.996±0.764 | 1.296±0.569† | 1.00±0.551*** |
| Rituximab | 1.680±0.763 | 1.184±0.906*** | 1.04±0.854*** |